Efficacy and Safety of Ebronucimab, a Monoclonal Antibody Against Pcsk9, in Patients With Hyperlipidemia: Result From a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study

被引：0
|
作者：
Zhen, Wang
Pei, Zhaohui
Chen, Jiyan
Zhang, Guogang
Li, Dongye
Xia, Yu
Li, Baiyong
Wang, Max
Ni, Xiang
Wang, Guoqin
Ge, Junbo
机构：
来源：
CIRCULATION | 2022年 / 146卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A10451
引用
收藏
页数：2
相关论文
共 50 条
  • [41] CGRP monoclonal antibody LY2951742 for the prevention of migraine: a phase 2, randomized, double-blind, placebo-controlled study
    Goadsby, P.
    Dodick, D.
    Spierings, E.
    Scherer, J.
    Sweeney, S.
    Grayzel, D.
    JOURNAL OF HEADACHE AND PAIN, 2014, 15
  • [42] Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
    Zhang, Bo
    Cheng, Zhifeng
    Chen, Ji
    Zhang, Xin
    Liu, Dexue
    Jiang, Hongwei
    Ma, Guoqing
    Wang, Xiaoyun
    Gan, Shenglian
    Sun, Juan
    Jin, Ping
    Yi, Jianjun
    Shi, Bimin
    Ma, Jianhua
    Ye, Shandong
    Wang, Guixia
    Ji, Linong
    Gu, Xuejiang
    Yu, Ting
    An, Pei
    Deng, Huan
    Li, Haoyu
    Li, Li
    Ma, Qingyang
    Qian, Lei
    Yang, Wenying
    DIABETES CARE, 2024, 47 (01) : 160 - 168
  • [43] A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 in Patients with Diabetic Gastroparesis
    Lembo, Anthony
    Camilleri, Michael
    McCallum, Richard W.
    Sastre, Ramon F.
    Breton, Cristian F.
    Spence, Sharon C.
    White, Jeffery
    Gottesdiener, Keith
    Stoner, Elizabeth
    GASTROENTEROLOGY, 2014, 146 (05) : S158 - S159
  • [44] Safety and Efficacy of KP1077 in a Phase 2, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Patients with Idiopathic Hypersomnia
    Braeckman, Rene
    Drake, Christopher
    Guenther, Sven
    Gallo, Daniel
    Vaughn, Ben
    Fattah, Ihab Abdel
    JOURNAL OF SLEEP RESEARCH, 2024, 33
  • [45] Efficacy and safety of anamorelin HCl in NSCLC patients: Results from a randomized, double-blind, placebo-controlled, multicenter phase II study
    Temel, J.
    Bondarde, S.
    Jain, M.
    Allen, S.
    Mann, W.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S269 - S270
  • [46] Clinical pharmacokinetics and pharmacodynamics of ongericimab: A potential long-acting PCSK9 monoclonal antibody in healthy subjects and patients with hypercholesterolemia: Randomized, double-blind, placebo-controlled phase Ia and Ib/II studies
    Jiang, Juanjuan
    Xu, Li
    Chai, Lin
    Guan, Xiaoyuan
    Zhang, Li
    Liu, Hong
    Yan, Yan
    Li, Lili
    Zhao, Yi
    Bai, Xuelian
    Tian, Lei
    Jia, Youhong
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (11):
  • [47] Design and Rationale of the LAPLACE-TIMI 57 Trial: A Phase II, Double-Blind, Placebo-Controlled Study of the Efficacy and Tolerability of a Monoclonal Antibody Inhibitor of PCSK9 in Subjects With Hypercholesterolemia on Background Statin Therapy
    Kohli, Payal
    Desai, Nihar R.
    Giugliano, Robert P.
    Kim, Jae B.
    Somaratne, Ransi
    Huang, Fannie
    Knusel, Beat
    McDonald, Shannon
    Abrahamsen, Timothy
    Wasserman, Scott M.
    Scott, Robert
    Sabatine, Marc S.
    CLINICAL CARDIOLOGY, 2012, 35 (07) : 385 - 391
  • [48] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
    Goodman, A. D.
    Rossman, H.
    Bar-Or, A.
    Miller, A.
    Miller, D. H.
    Schmierer, K.
    Lublin, F.
    Khan, O.
    Bormann, N. M.
    Yang, M.
    Panzara, M. A.
    Sandrock, A. W.
    NEUROLOGY, 2009, 72 (09) : 806 - 812
  • [49] Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study
    Gupta, Pawan Kumar
    Maheshwari, Sunil
    Cherian, Joe Joseph
    Goni, Vijay
    Sharma, Arun Kumar
    Tripathy, Sujith Kumar
    Talari, Keerthi
    Pandey, Vivek
    Sancheti, Parag Kantilal
    Singh, Saurabh
    Verma, Nikhil N.
    Kumar, Uday
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2023, 51 (09): : 2254 - 2266
  • [50] Efficacy and safety of fasudil in patients with stable angina - A double-blind, placebo-controlled, phase 2 trial
    Vicari, RM
    Chaitman, B
    Keefe, D
    Smith, WB
    Chrysant, SG
    Tonkon, MJ
    Bittar, N
    Weiss, RJ
    Morales-Ballejo, H
    Thadani, U
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (10) : 1803 - 1811
12345